While insulin pumps and continuous glucose monitors have improved the lives of many Type 1 diabetes patients, some still cannot maintain steady control. Implantable insulin pumps offer another option ...

Abstract: This paper describes personalised, intelligent methods for designing an automated artificial pancreas (AP) to regulate type 1 diabetes blood sugar. Initial insulin-glucose regulation can be ...

Medtronic CTO Jim Peichel [Image from Peichel’s LinkedIn feed] Medtronic (NYSE: MDT) + has promoted the head of its Cardiac Implantables Technology Development Center to be its new chief technology ...

[Image from Modular Medical on LinkedIn] Modular Medical (Nasdaq:MODD) announced that it has submitted its next-generation Pivot insulin pump to the FDA for clearance. Modular Medical’s current pump, ...

Medtronic’s pulsed field ablation business took off last quarter as competition in the space continues to heat up nearly two years after products first launched. PFA sales grew by more than 300% year ...

Submission delayed by U.S. government shutdown; initial FDA questions expected during Q4 2025 "The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch ...

Abstract: The insulin pump is a critical device for intensive insulin therapy in diabetic patients. Failures in insulin pump sets such as blockage and leakage can disrupt normal insulin delivery, ...

[Image from Renu MedTech on LinkedIn] Renu MedTech today unveiled InsuPatch, its tubeless insulin patch pump designed specifically for advancing diabetes care in India. On LinkedIn, the Pune, ...